Madjore, Nerma A.

HRN: 16-56-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2024
CEFUROXIME 500MG (TAB)
01/11/2024
01/12/2024
IV
2grams
Q6hr
Premature Ruptuted Of Membrane
01/11/2024
AMPICILLIN 1GM (VIAL)
01/11/2024
01/18/2024
IV
2grams
Q6hr
Premature Ruptuted Of Membrane
Waiting Final Action 
01/11/2024
CEFUROXIME 500MG (TAB)
01/11/2024
01/17/2024
PO
1tab
BID
Thinly MSAF; RMLE
Waiting Final Action 
01/11/2024
METRONIDAZOLE 500MG (TAB)
01/11/2024
01/17/2024
PO
1tab
TID
Thinly Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: